The University of Washington Division of Rheumatology is committed to supporting biomedical research endeavors to improve rheumatic and autoimmune disease outcomes. Led by Dr. Bobby Han, we partner with practicing physicians and industry sponsors to conduct health-related interventional and observational studies.
|Disease Indication||Study Information|
|Systemic Lupus Erythematosus||
IM011-021: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of BMS-986165 in Subjects with Systemic Lupus Erythematosus
IM011-073: A Phase 2 Randomized, Double-blind, Placebo-controlled Evaluation of the Safety and Efficacy of BMS-986165 with Background Treatment in Subjects with Lupus Nephritis
|Giant Cell Arteritis||
M16-852: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Upadacitinib in Subjects with Giant Cell Arteritis
STUDY00004744: Phase IV Open-Label Study to Evaluate Biomarkers to Predict the Efficacy of Abatacept in Subjects with Rheumatoid Arthritis
|Systemic Lupus Erythematosus or Healthy Adults||
HSD50655: Photoprovocation Testing in Subjects with Systemic Lupus Erythematosus
|Open to All||
STUDY00003007: Rheumatic Disease Biorepository & Patient Registry
Upcoming Study Areas
Stay tuned for more information on upcoming studies for Systemic Lupus Erythematosus, Rheumatoid Arthritis, Giant Cell Arteritis, Lupus Nephritis, Psoriatic Arthritis and Scleroderma.
Connect with the team via email or call to speak with our Research Manager.
If you have questions, are interested in participating, or want to sponsor a study at our site, let us know!